Journal Article

Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction

Mari Fihlman; Tuija Hemmilä; Nora M. Hagelberg; Kristiina Kuusniemi; Janne T. Backman; Jouko Laitila; Kari Laine; Pertti J. Neuvonen; Klaus T. Olkkola; Teijo I. Saari

European Journal of Clinical Pharmacology · Vol. 72, Issue 11 · pp. 1363-1371 · 2016

View Full Text Download RIS Journal Homepage

Abstract

Abstract is unavailable.

Bibliographic Information

Journal	European Journal of Clinical Pharmacology
Publisher	Springer
Publication Date	2016-11-01
Publication Year	2016
Volume	72
Issue	11
Pages	1363-1371
Document Type	Journal Article
Print ISSN	0031-6970
eISSN	1432-1041
DOI	10.1007/s00228-016-2109-y

Access Information

NARA Access Coverage	1968-01-01~Current
Journal Homepage	https://www.springer.com/journal/228
Publisher Page	Open Publisher Page

Full-text access depends on NARA's subscribed coverage and institutional access.